Project Grant R43DA047150

This $591,032 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development of the "COGITO" digital therapeutics platform. COGITO is intended to provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics to prevent, treat, or manage a wide range of health conditions with behavioral components. The funding will be used to finalize key...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project titled "Implementing a Digital Therapeutic to Address Substance Use Disorders Among People Who Are Incarcerated." The $355,414 award to Yale University will fund a 5-year study to assess the feasibility, acceptability, and preliminary efficacy of implementing an evidence-based digital therapeutic, Computer-Based...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop and evaluate a customized version of the "MyTrials" remote biomarker capture system for use in decentralized clinical trials (DCTs) for substance use disorders (SUDs). The key products and services to be delivered include: 1) Refinement of the existing MyTrials prototype to support the...

This federal Project Grant award of $683,611 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) supports research to optimize the engagement and clinical outcomes of a "smart" digital therapeutic for alcohol use disorder (AUD). The project aims to embed a machine learning-based lapse prediction model into an existing digital therapeutic called A-CHESS and evaluate how different components of daily engagement messages...

The National Science Foundation (NSF) Division of Information and Intelligent Systems awarded a $162,827 Project Grant to the University of Wisconsin - Madison, through the University of Wisconsin System, to develop an "Intelligent Pervasive Augmented Reality Therapy (IPAL)" system for managing opioid use disorder (OUD) and addiction. The 1-year project will integrate complementary psychotherapies like cognitive behavioral therapy and heart rate variability biofeedback with immersive...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...

The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $304,023 Project Grant to Evidation Health, Inc. to develop a digital platform called "RESHAPE" that addresses health-related social needs (HRSN) impacting substance use disorder (SUD) recovery. The project aims to create a comprehensive digital experience that provides personalized education, insights, and support to improve the well-being and self-efficacy of...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,338,750 to The Ohio State University to develop and pilot a brief, digitally-enhanced intervention called IMPROVE for reducing alcohol use among individuals receiving medications for opioid use disorder (MOUD). The project has two phases: (1) adapting the IMPROVE intervention content, delivery, and digital tools based on expert and...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $680,046 to the Medical University of South Carolina to conduct a study on "REAL-WORLD ASSESSMENT OF SOCIAL FUNCTIONING DURING OUD TREATMENT: INTEGRATING REPORTS FROM PATIENTS AND THEIR CONCERNED SIGNIFICANT OTHERS." The study aims to examine how social engagement behaviors, social reward, and social connection change and are...

This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...